Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Mertens

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
American Journal of Clinical Oncology|December 18, 1998
Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trialsL E Flaherty, J M Unger, P Y Liu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 1, 1994
Glutathione S-transferase expression in renal cell carcinoma: a new marker of differentiationD J Grignon, M Abdel-Malak, W C Mertens, et al.
Cancer Immunology, Immunotherapy : CII|November 1, 1995
High-dose continuous venous infusion of interleukin-2: influence of dose and infusion rate on tumoricidal function and lymphocyte subsetsW C Mertens, D Banerjee, N al-Mutter, et al.
Lancet (London, England)|August 15, 1992
Effect of indomethacin plus ranitidine in advanced melanoma patients on high-dose interleukin-2W C Mertens, V H Bramwell, F Gwadry-Sridhar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1993
Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials GroupW C Mertens, E A Eisenhauer, M Moore, et al.
Cancer Biotherapy|January 1, 1993
Sustained oral indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced renal cell carcinomaW C Mertens, V H Bramwell, D Banerjee, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
American Journal of Clinical Oncology|December 18, 1998
Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trialsL E Flaherty, J M Unger, P Y Liu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 1, 1994
Glutathione S-transferase expression in renal cell carcinoma: a new marker of differentiationD J Grignon, M Abdel-Malak, W C Mertens, et al.
Cancer Immunology, Immunotherapy : CII|November 1, 1995
High-dose continuous venous infusion of interleukin-2: influence of dose and infusion rate on tumoricidal function and lymphocyte subsetsW C Mertens, D Banerjee, N al-Mutter, et al.
Lancet (London, England)|August 15, 1992
Effect of indomethacin plus ranitidine in advanced melanoma patients on high-dose interleukin-2W C Mertens, V H Bramwell, F Gwadry-Sridhar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1993
Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials GroupW C Mertens, E A Eisenhauer, M Moore, et al.
Cancer Biotherapy|January 1, 1993
Sustained oral indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced renal cell carcinomaW C Mertens, V H Bramwell, D Banerjee, et al.
Pageof 3